Sabby Management, LLC Incyte Corp Transaction History

Sabby Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$61.75 - $74.23 $2.56 Million - $3.07 Million	-41,419 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$60.85 - $83.98 $2.46 Million - $3.4 Million	-40,442 Reduced 49.4%	41,419 $2.78 Million
Q1 2018 May 15, 2018	BUY	$83.06 - $100.98 $6.8 Million - $8.27 Million	81,861 New	81,861 $6.82 Million

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.